Influenza

NIH Trial of Six-Strain Universal Flu Vaccine Candidate Begins

The nanoparticle vaccine candidate, FluMos-v2, builds on its predecessor FluMos-v1 and is designed to induce antibodies against six flu strains.

Influenza

Clean Air Found to Speed Up Airborne Virus Destruction

New research reveals how cleaner air kills airborne viruses significantly quicker and why opening a window may be more important than originally thought.

Influenza

NIAID’s Universal Flu Vaccine Candidate Advances to Second Trial

In a phase 1 clinical trial, the vaccine developed by NIAID's Vaccine Research Center was safe, well-tolerated, and induced broad antibody responses that target the hemagglutinin stem.

Investigational Immune Activating Platform Boosts Influenza Vaccine Response

by RT Staff | Feb 17, 2023 | Influenza | 0

The preclinical research demonstrated the ability of Infectimune to significantly boost CD4 T cell activity, suggesting that Infectimune-based vaccines could provide durable protection against seasonal flu and potentially emerging pandemic flu.

Vaxxas Starts Clinical Trial for Needle-Free, Seasonal Flu Patch

by RT Staff | Feb 16, 2023 | Clinical Trials, Influenza | 0

The trial will assess the safety, tolerability, and immunogenicity of the IIV4 candidate in approximately 150 healthy participants, aged 18 to 50.

AAHI Awarded $9.9M to Develop Nasal Spray Influenza Vaccine

by RT Staff | Feb 15, 2023 | Influenza | 0

The 40-month project may culminate in a prototype bivalent vaccine candidate that is effective against both the H5N1 and H7N9 strains of influenza, according to Access to Advanced Health Institute.

Researchers Identify Compound That Inhibits Influenza Virus Replication

by RT Staff | Feb 15, 2023 | Influenza | 0

Researchers have discovered a compound that inhibits the body’s own methyltransferase MTr1, which limits the replication of influenza viruses and may lead to the development of new treatments for the flu.

Nearly 40% of Households Report Recent Illness from RSV, COVID-19, or Flu

by RT Staff | Feb 8, 2023 | Influenza, Other Infections | 0

A poll of 1,234 adults aimed to determine how many households had recently been impacted by RSV, COVID-19 or the flu and to gauge their concern about whether they’re worried about becoming ill with one of the viruses.

FDA Green-lights BD’s Combo RSV, Flu, COVID Test

by RT Staff | Feb 8, 2023 | FDA Approvals, Influenza, Other Infections, Testing | 0

BD received FDA emergency use authorization for its new molecular diagnostic combination test for SARS-CoV-2, Influenza A + B and respiratory syncytial virus (RSV).